Which of the following is not a driving force shaping the pharmaceutical industry? choose from from these options: a$)$ Difficulty in discovering broad$-$based impactful new products. b$)$ Newer innovative research, discovery, & development methods $($Genomic$/$Personalized medicine$).$ c$)$ Increased payer requirements for HEOR data in order to provide formulary access and coverage. d$)$ Decreased regulatory demands and scrutiny pre and post approval.